IP Verse

Isoxazoline Parasiticide Formulations And Methods For Treating Blepharitis - EP3723739

The patent EP3723739 was granted to Tarsus Pharmaceuticals on Mar 27, 2024. The application was originally filed on Dec 14, 2018 under application number EP18889875A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3723739

TARSUS PHARMACEUTICALS
Application Number
EP18889875A
Filing Date
Dec 14, 2018
Status
Granted And Under Opposition
Feb 23, 2024
Grant Date
Mar 27, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKDec 23, 2024ELKINGTON AND FIFEADMISSIBLE
HOFFMANN EITLEDec 12, 2024HOFFMANN EITLEADMISSIBLE

Patent Citations (33) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2010137372
DESCRIPTIONUS2010179194
DESCRIPTIONUS2010179195
DESCRIPTIONUS2010254960
DESCRIPTIONUS2011059988
DESCRIPTIONUS2011086886
DESCRIPTIONUS2013344128
DESCRIPTIONUS7662972
DESCRIPTIONUS7951828
DESCRIPTIONUS7964204
DESCRIPTIONUS8383659
DESCRIPTIONUS8466115
DESCRIPTIONWO2007070606
DESCRIPTIONWO2007075459
DESCRIPTIONWO2007123855
DESCRIPTIONWO2010003923
INTERNATIONAL-SEARCH-REPORTUS2013023490
INTERNATIONAL-SEARCH-REPORTUS2013053374
INTERNATIONAL-SEARCH-REPORTUS2013109642
INTERNATIONAL-SEARCH-REPORTUS2013344128
INTERNATIONAL-SEARCH-REPORTUS2017020849
INTERNATIONAL-SEARCH-REPORTWO9415597
OPPOSITIONUS2007066617
OPPOSITIONUS2009061025
OPPOSITIONUS2012053140
OPPOSITIONUS2013344128
OPPOSITIONUS2017020849
OPPOSITIONUS2017239218
OPPOSITIONWO2016102437
OPPOSITIONWO2017180788
SEARCHEP2379537
SEARCHUS2017239218
SEARCHWO2016102437

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- YEU ELIZABETH ET AL, "Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)", US, vol. Publish Ahead of Print, doi:10.1097/ICO.0000000000003097, ISSN 0277-3740, (20220811), pages 1 - 9, CORNEA: THE JOURNAL OF CORNEA AND EXTERNAL DISEASE, URL: https://journals.lww.com/corneajrnl/Fulltext/9900/Lotilaner_Ophthalmic_Solution,_0_25_,_for_the.91.aspx, XP093017544
OPPOSITION- D2 - Declaration by Dr. B. R. Azamian-
OPPOSITION- Leinart Linzey Barbara, "Comparison of Efficacy, Side Effects, and Cost of Isoxasolines and Ivermectin Against Generalized Canine Demodicosis", Bachelor's Thesis, University of Arizona, (20170101), Bachelor's Thesis, University of Arizona, URL: https://repository.arizona.edu/bitstream/handle/10150/625036/azu_etd_hr_2017_0111_sip1_m.pdf?sequence=1&isAllowed=y, XP093239418-
OPPOSITION- Flávio Gaieta Holzchuh; Richard Yudi Hida; Bernardo Kaplan Moscovici; Marcos Bottene Villa Albers; Ruth Miyuki Santo; Newton Kara-José; Ricardo Holzchuh;, "Clinical Treatment of Ocular Demodex folliculorum by Systemic Ivermectin", American Journal of Ophthalmology, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL , (20101122), vol. 151, no. 6, doi:10.1016/j.ajo.2010.11.024, ISSN 0002-9394, pages 1030 - 1034.e1, XP028219023
OPPOSITION- Ozoe, Y. ; Asahi, M. ; Ozoe, F. ; Nakahira, K. ; Mita, T., "The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels", Biochemical and Biophysical Research Communications, Elsevier, Amsterdam NL, Amsterdam NL , (20100101), vol. 391, no. 1, doi:10.1016/j.bbrc.2009.11.131, ISSN 0006-291X, pages 744 - 749, XP026823770
OPPOSITION- Beugnet Frédéric, Halos Lénaïg, Larsen Diane, De Vos Christa, "Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis", Parasite, (20160101), vol. 23, doi:10.1051/parasite/2016014, page 14, XP055907826
OPPOSITION- Yeu Elizabeth, Wirta David L., Karpecki Paul, Baba Stephanie N., Holdbrook Mark, "Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)", Cornea, Masson Pub. USA, (20220811), vol. Publish Ahead of Print, doi:10.1097/ICO.0000000000003097, ISSN 0277-3740, pages 1 - 9, XP093017544
OPPOSITION- Przemyslaw Baranowski, Et Al., "Ophthalmic Drug Dosage Forms: Characterisation and Research Methods", The Scientific World Journal, Hindawi Limited, (20140101), vol. 2014, doi:10.1155/2014/861904, ISSN 2356-6140, pages 1 - 14, XP055643530
OPPOSITION- Snyder Daniel E., Wiseman Scott, Liebenberg Julian E., "Efficacy of lotilaner (Credelio™), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp.", Parasites & Vectors, (20171201), vol. 10, no. 1, doi:10.1186/s13071-017-2472-2, XP055900891
SEARCH[ ] - GONZALEZ-SALINAS ROBERTO ET AL, "Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Pilot Study", US, vol. 2021, doi:10.1155/2021/3862684, ISSN 2090-004X, (20210921), pages 1 - 7, JOURNAL OF OPHTHALMOLOGY, URL: http://downloads.hindawi.com/journals/joph/2021/3862684.xml, XP055900963 [ ] * abstract * * page 2, column 1, paragraph 3 - column 2, paragraph 2 * * page 3, column 2, paragraph 5 - page 5, column 1, paragraph 3 * * page 5, column 2, paragraph 6 *
SEARCH- SNYDER DANIEL E. ET AL, "Efficacy of lotilaner (Credelio(TM)), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp.", vol. 10, no. 1, doi:10.1186/s13071-017-2472-2, (20171101), PARASITES & VECTORS, URL: http://link.springer.com/content/pdf/10.1186/s13071-017-2472-2.pdf, XP055900891 [A] 1-11 * abstract * * page 6, column 1, paragraph l - column 2, paragraph 1 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents